iShares Health Innovation Active ETF (NYSEARCA:BMED) Sees Significant Increase in Short Interest

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totaling 1,472 shares, an increase of 159.2% from the May 31st total of 568 shares. Based on an average daily trading volume, of 1,249 shares, the short-interest ratio is currently 1.2 days. Currently, 0.4% of the shares of the company are short sold.

iShares Health Innovation Active ETF Stock Performance

BMED opened at $30.58 on Monday. The firm’s 50 day simple moving average is $28.36 and its two-hundred day simple moving average is $29.55. The company has a market capitalization of $11.01 million, a PE ratio of 24.91 and a beta of 0.75. iShares Health Innovation Active ETF has a 1-year low of $24.50 and a 1-year high of $32.19.

Hedge Funds Weigh In On iShares Health Innovation Active ETF

A hedge fund recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. purchased a new stake in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned 3.63% of iShares Health Innovation Active ETF as of its most recent filing with the Securities & Exchange Commission.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.